2.If the Agency recommends the authorisation of the same product, the opinion shall contain at least both the following elements:
(a)a statement on whether the conditions laid down in Article 19 of Regulation (EU) No 528/2012 are fulfilled, and a draft summary of biocidal products characteristics, as referred to in Article 22(2) of that Regulation;
(b)where relevant, details of any terms and conditions which should be imposed on the making available on the market and use of the same product.